Page last updated: 2024-11-04

rolipram and Alveolitis, Fibrosing

rolipram has been researched along with Alveolitis, Fibrosing in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Roflumilast was approximately 10-fold more potent than rolipram."1.35PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts. ( Ahn, Y; Ertl, RF; Fredriksson, K; Holz, O; Kamio, K; Kawasaki, S; Kobayashi, T; Liu, X; Magnussen, H; Rennard, SI; Skold, CM; Sugiura, H; Togo, S; Wang, X, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Togo, S1
Liu, X1
Wang, X1
Sugiura, H1
Kamio, K1
Kawasaki, S1
Kobayashi, T1
Ertl, RF1
Ahn, Y1
Holz, O1
Magnussen, H1
Fredriksson, K1
Skold, CM1
Rennard, SI1
de Visser, YP1
Walther, FJ1
Laghmani, EH1
van Wijngaarden, S1
Nieuwland, K1
Wagenaar, GT1

Other Studies

2 other studies available for rolipram and Alveolitis, Fibrosing

ArticleYear
PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
    American journal of physiology. Lung cellular and molecular physiology, 2009, Volume: 296, Issue:6

    Topics: Adult; Aminopyridines; Benzamides; Cells, Cultured; Chemotaxis; Collagen; Cyclic AMP; Cyclic Nucleot

2009
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury.
    The European respiratory journal, 2008, Volume: 31, Issue:3

    Topics: Animals; Animals, Newborn; Benzamides; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Gene Ex

2008